Document Detail


The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
MedLine Citation:
PMID:  18461399     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: 18-Fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) has a role in recurrent colorectal cancer. This study was designed to assess the impact of PET-CT on management of primary rectal cancer. METHODS: Eighty-three patients with rectal cancer underwent PET-CT scan between 2002 and 2005. Referring physicians prospectively recorded stage and management plan after conventional imaging before PET-CT scan, which were compared to subsequent stage and management after PET-CT. RESULTS: Staging PET-CT caused a change in stage from conventional imaging in 26 patients (31 percent). Twelve (14 percent) were upstaged (7 change in N stage; 4 change in M stage; 1 change in N and M stage), and 14 (17 percent) were downstaged (10 change in N stage; 3 change in M stage; 1 change in N and M stage). PET-CT scan altered management intent in seven patients (8 percent) (curative to palliative 6 patients; palliative to curative 1 patient). Management was altered in ten patients (12 percent). There was no difference in impact with respect to tumor height. CONCLUSIONS: PET-CT scan impacts the management of patients with primary rectal cancer and influences staging/therapy in a third of patients and should be a component of rectal cancer workup.
Authors:
K Davey; A G Heriot; J Mackay; E Drummond; A Hogg; S Ngan; A D Milner; R J Hicks
Related Documents :
10849539 - Imaging of malignant cervical lymphadenopathy.
17631559 - 68ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: compari...
15788619 - Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative ...
16474909 - Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scannin...
17180659 - Integrated pet/ct as a first-line re-staging modality in patients with suspected recurr...
18424949 - Positron emission tomography/computed tomography and whole-body magnetic resonance imag...
18727039 - Improved calibration technique for in vivo proton mrs thermometry for brain temperature...
446409 - Tumor growth and calcitonin during serial transplantation of rat medullary thyroid carc...
10762199 - Spinal subdural tuberculous abscess.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2008-05-07
Journal Detail:
Title:  Diseases of the colon and rectum     Volume:  51     ISSN:  1530-0358     ISO Abbreviation:  Dis. Colon Rectum     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-07-03     Completed Date:  2008-07-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372764     Medline TA:  Dis Colon Rectum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  997-1003     Citation Subset:  IM    
Affiliation:
Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / pathology,  radionuclide imaging*,  therapy*
Adult
Aged
Aged, 80 and over
Biopsy
Combined Modality Therapy / methods
Female
Fluorodeoxyglucose F18 / diagnostic use*
Follow-Up Studies
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neoplasm Staging / methods
Positron-Emission Tomography / methods*
Prognosis
Prospective Studies
Radiopharmaceuticals / diagnostic use*
Rectal Neoplasms / pathology,  radionuclide imaging*,  therapy*
Reproducibility of Results
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prognostic value of endoanal ultrasound for fistula-in-ano: a retrospective analysis.
Next Document:  Significant rectal bleeding as a complication of a fecal collecting device: report of a case.